Trimethoprim

6 trials 3 recruiting JAnti-infectives

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

3 Recruiting

1 Completed trials

6 Sponsors

12 Countries

Phase III

Phase II

Phase IV

Phase III: 3 Phase II: 1 Phase IV: 2

Oversight events:

1 serious breach across 1 trial

View oversight register →

Indications tested

Mycobacterium abscessus infection 1 Spinal cord injury 1

Sponsors using this IMP

Centre Hospitalier Universitaire De Nantes 1 Friedrich-Schiller-Universitaet Jena 1 Hansa Biopharma AB 1 Region Hovedstaden 1 Rigshospitalet 1 The University Of Queensland 1

All trials

6 total

ANTIBIOBONTA - Assessment of the interest of a peri-operative antibiotic strategy applied to patients with asymptomatic bacteriuria undergoi… Pending

2024-515107-19-00 Phase III 1 country Centre Hospitalier Universitaire De Lille
Efficacy and safety of Dalbavancin in the treatment of infective Endocarditis caused by gram-positive cocci Pending

2026-526149-91-00 Phase III 1 country Friedrich-Schiller-Universitaet Jena
REINFORCE – Reducing infection-related readmissions following cystectomy. Recruiting

2024-514312-27-00 Phase IV 1 country Rigshospitalet
Short course antibiotic treatment of Gram-negative bacteremia: A multicenter, randomized, non-blinded, non-inferiority interventional study Recruiting

2024-514900-16-00 Phase IV 1 country Region Hovedstaden
Finding the best treatment for lung disease from infection with Mycobacterium abscessus Recruiting

2023-506575-99-00 Phase II 1 country The University Of Queensland
A Phase 3 open-label, controlled, randomised, multi-centre trial comparing imlifidase and standard-of-care with standard-of-care alone in th… Ended

2022-500121-33-01 Phase III 12 countries Hansa Biopharma AB

Showing 1–6 of 6 trials

← All drugs A–Z